Page 114 - Ebook-Book JCMS 2025

Outcomes after Using the REMI Application Compared with
Usual Care in Gestational Diabetes Treatment: A Randomized
Study
Kornsulee Srisuwatcharee1*, Thipaporn Tharavanij2-5, Korawat Phonyiam6, Piyawan Thongploy6
,
Supiya Charoensiriwath6, Pimjai Anthanont 2-3, Peeradon Vibhatavata 2-3, Somvong Vongterapak2-3
,
Sudathip Kositamongkol7, Nattamon Tanathornkirati3, Saranrat Boonsawat8, Charintip Somprasit 9-10
1 Department of Medicine, Faculty of Medicine, Thammasat University
2 Endocrinology and Metabolism Unit, Department of Medicine, Faculty of Medicine, Thammasat University
3 Thammasat Diabetes Center of Excellence, Thammasat University Hospital
4 Center of Excellence in Applied Epidemiology, Thammasat University
5 Center of Excellence in Nexus for Advanced Intelligence in Law, Engineering, and Medicine (Nail’Em)
6 National Electronics and Computer Technology Center, National Science and Technology Development
Agency
7 The Neonatal and Perinatal Unit, Department of Pediatrics, Faculty of Medicine, Thammasat University
8 Department of nutrition, Thammasat University
9 Maternal -Fetal -Medicine unit, Department of Obstetrics and Gynecology, Faculty of Medicine, Thammasat
University
10 Thammasat University Research Unit in Advanced clinical data statistics analysis and innovative research
in obstetrics and gynecology group
*Corresponding Author E-mail: huiling.panda@gmail.com
Background: Abstract
A Robot for Expecting Mother’s Information (REMI) application provides features such
as body weight, food intake, and glucose record, which medical personnel can remotely
monitor and educate patients. Using the REMI application may facilitate good glycemic
control in gestational diabetes (GDM).
Methods: An open-label, randomized controlled study in GDM was conducted. The participants in
the REMI group (n=26) and the UC group (n=31) met medical personnel for education
about lifestyle modification. They had to record daily food intake and perform blood glucose
monitoring 2-4 times/day. REMI group reported the results via the application. The medical
personnel reviewed the results and educated them weekly via application. Insulin therapy
would be initiated if blood glucose readings exceeded these targets in at least 50% of the
measurements. In-person visits were arranged at least once a month until delivery. The UC
group recorded the results on paper and had regular in-person visits every 1-2 weeks. The
primary goal was to compare glycemic control between REMI and usual care (UC) groups in
GDM participants. The secondary goals were maternal and neonatal complications.
112 Joint Conference in Medical Sciences 2025